Pharma Journalist -

FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) announced that it has entered into an agreement to acquire a cell therapy manufacturing facility…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the adjuvant…
Read More...

Cocrystal Pharma, Inc. has selected two investigational novel antiviral drug candidates for further development as oral treatments for SARS-CoV-2, the virus that causes COVID-19.…
Read More...

Cryoport, Inc. announced that it has entered into a strategic partnership with Cell Matters, S.A. to deliver to the life sciences industry end-to-end cryopreservation services for…
Read More...

Ocugen, Inc. a biopharmaceutical company focused on discovering, developing, and commercializing breakthrough gene therapies and vaccines, announced that it has signed a non-binding…
Read More...

HaemaLogiX Ltd (HaemaLogiX), the clinical-stage biotechnology company developing novel monoclonal antibody therapies for multiple myeloma, and Lonza, a global development and…
Read More...

Atara Biotherapeutics, Inc. a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and…
Read More...

SMi Group reports: registration closing soon, secure your place at the RNA Therapeutics Conference with one week left to go! With just two weeks remaining until SMi’s 13th Annual RNA…
Read More...

Crowell & Moring launched a strategic consulting firm today called Crowell Health Solutions to help health care organizations and technology companies transform health care by…
Read More...